“…As a gastric mucosa-colonizing microorganism, H. pylori may contribute to the bidirectional nature of the brain-gut axis as evidenced by: (1) the overlapping of upper and lower digestive tract functional symptoms in H. pylori infected patients [18,[41][42][43] and the effect of H. pylori infection on IBS symptoms [43] (but see Breckan et al [44] ) and pancreatic juice secretion [45] ; (2) the protection against IBD appearance by H. pylori infection [17,46] resulting from changes induced in brain-gut axis function (neuroendocrine-immune crosstalk) [6,15,21,22,26,47,48] ; (3) the association of H. pylori infection with ANS-related extra-digestive diseases, such as atherosclerosis or cardiac arrhythmia [3,35] ; (4) the improved physical and psychological health-related quality of life and sexual relationships after digestive tract symptom alleviation and H. pylori eradication [49,50] ; (5) the proposed association between H. pylori infection and the development of axonal type Guillain-Barré neuropathy, multiple sclerosis and epilepsy [51][52][53] , and case reports of gastric MALT lymphoma followed by primary CNS lymphoma [54] ; and (6) the modulation of ANS balance by H. pylori infection [35] . Furthermore, H. pylori can potentially regulate esophageal motility [55] , gastric emptying, gastric accommodation of ingested food, gastric acid secretion, mucosal blood flow, hypersensitivity to chemoand mechano-stimulants [56] , food intake [6,19] , digestive tract endocrine and immune functions and the composition of gut microbiota [6,18,21,22] , by influencing the release of various neurotransmitters, including acetylocholine (vagal nerve, parasympathetic part), noradrenaline, adrenaline and sympathetic dopamine, as well as the neuropeptides leptin, ghrelin, calcitonin gene-related peptide (CGRP), nitric oxide, neuropep...…”